Web contents challenger Forums
Would you like to react to this message? Create an account in a few clicks or log in to continue.

WHO Europe Regional Off.: Summary of Middle East respiratory syndrome coronavirus (MERS-CoV), 9 July 2013 2013

Go down

WHO Europe Regional Off.:  Summary of Middle East respiratory syndrome coronavirus (MERS-CoV), 9 July 2013 2013 Empty WHO Europe Regional Off.: Summary of Middle East respiratory syndrome coronavirus (MERS-CoV), 9 July 2013 2013

Post by Guest Tue Jul 09, 2013 12:28 pm

2013 2013 2013 <h3 style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; margin: 10px 0px 5px; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">Available in:</h3><ul class="menu" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; list-style-image: url(http://www.euro.who.int/__data/assets/image/0016/42631/list-arrow.gif); margin: 10px 0px 0px 17px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><li style="color: #333333; left: -4px; margin-bottom: 10px;"><span style="color: blue;"><a href="http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf" style="text-decoration: none;" title="WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV), 9 July 2013">English</a></span><span class="Apple-converted-space">&nbsp;</span>(PDF), 167.2 KB</li></ul><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">This update summarizes available information and WHO recommendations as of 9 July 2013 related to human infections with Middle East respiratory syndrome coronavirus (MERSCoV) for Member States of the WHO European Region.</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">What is new in this update?<br />• The total number of laboratory confirmed cases as of 5 July is 79 cases with 42 <br />reported deaths (page 3)<br />• Convening of an Emergency Committee under the International Health <br />Regulations(IHR) (page 3)<br />• The WHO interim MERS-CoV surveillance guidance has been updated and the <br />latest version was posted on 27 June (page 4)<br />• Publication of WHO guidelines for investigation of cases of human infection with <br />Middle East Respiratory Syndrome Coronavirus (MERS-CoV) (page 5)<br />• Recommendations on preparedness measures to be taken (page 6). <br />• The laboratory testing for novel coronavirus – interim recommendations is now <br />available in Russian (page 7)</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>&nbsp;</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>&nbsp;</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>Excerpt:</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">2. <b>Situation update and assessment</b><br />As of 5 July 2013, and since April 2012, 79 laboratory-confirmed cases of human infection with MERSCoV have been reported to WHO, of which 42 have died. Countries that have reported cases are Jordan, <br />Qatar, Saudi Arabia, Tunisia and the United Arab Emirates (UAE). Cases have also been reported by four <br />countries in the WHO European Region (France, Germany, Italy and the United Kingdom). <b>All European <br />and North African cases have had a direct or indirect connection to the Middle East</b>. <span style="color: red;">In France, Italy, the United Kingdom and Tunisia there has been limited local transmission among close contacts who had not been to the Middle East but had been in contact with a sick traveller recently returned from the Middle East. </span><br /><b>The newest cases reported indicate that the source of infection remains active in the Middle East and is present throughout a large area.</b> The first case in Tunisia was likely infected in Qatar; however, this cannot be definitively shown without further investigation. Both the Tunisian and Qatari public health <br />authorities are pursuing further investigations. </div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /><b>The appearance of cases in Europe and North Africa but not in other countries with frequent travel in and out of the Middle East is likely a result of differences in surveillance and testing.</b> All Member States are encouraged to remind travellers returning from the affected area to seek medical attention if they develop a respiratory illness, and to test those who meet the profile described in the current surveillance recommendations posted on the WHO coronavirus web site.</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br />Human-to-human transmission has not been observed to persist beyond small clusters of individuals <br />with close contact. However, it is likely that more sporadic cases with subsequent limited transmission <br />will occur in the near future. The large number of cases with reported co-morbidities suggests that <br />persons with underlying medical conditions may have increased susceptibility to infection1<br />. <br />Convening of an Emergency Committee under the International Health Regulations (IHR)<br />WHO is convening an Emergency Committee under the IHR for MERS-CoV, which will meet on 9 and 11 <br />July 2013. The outcome of the Emergency Committee will be announced on the WHO web site and will <br />also be summarized in the next WHO/Europe MERS-CoV summary.<br />&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>Clinical presentation of MERS-CoV</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /><b>The majority of cases have respiratory disease, from mild symptoms to severe pneumonia. The clinical <br />presentation includes acute respiratory illness with fever, cough, shortness of breath, breathing <br />difficulties and pneumonia. Atypical symptoms including diarrhoea and renal failure can be predominant <br />if the patient is immunocompromised. Recently, a small number of asymptomatic cases have been <br />detected through contact tracing among close contacts of cases. </b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><a href="http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf">http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf</a></div><br> 2013 2013 2013 <br><h3 style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; margin: 10px 0px 5px; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">Available in:</h3><ul class="menu" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; list-style-image: url(http://www.euro.who.int/__data/assets/image/0016/42631/list-arrow.gif); margin: 10px 0px 0px 17px; orphans: auto; padding: 0px; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><li style="color: #333333; left: -4px; margin-bottom: 10px;"><span style="color: blue;"><a href="http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf" style="text-decoration: none;" title="WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV), 9 July 2013">English</a></span><span class="Apple-converted-space">&nbsp;</span>(PDF), 167.2 KB</li></ul><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">This update summarizes available information and WHO recommendations as of 9 July 2013 related to human infections with Middle East respiratory syndrome coronavirus (MERSCoV) for Member States of the WHO European Region.</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">What is new in this update?<br />• The total number of laboratory confirmed cases as of 5 July is 79 cases with 42 <br />reported deaths (page 3)<br />• Convening of an Emergency Committee under the International Health <br />Regulations(IHR) (page 3)<br />• The WHO interim MERS-CoV surveillance guidance has been updated and the <br />latest version was posted on 27 June (page 4)<br />• Publication of WHO guidelines for investigation of cases of human infection with <br />Middle East Respiratory Syndrome Coronavirus (MERS-CoV) (page 5)<br />• Recommendations on preparedness measures to be taken (page 6). <br />• The laboratory testing for novel coronavirus – interim recommendations is now <br />available in Russian (page 7)</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>&nbsp;</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>&nbsp;</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>Excerpt:</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">2. <b>Situation update and assessment</b><br />As of 5 July 2013, and since April 2012, 79 laboratory-confirmed cases of human infection with MERSCoV have been reported to WHO, of which 42 have died. Countries that have reported cases are Jordan, <br />Qatar, Saudi Arabia, Tunisia and the United Arab Emirates (UAE). Cases have also been reported by four <br />countries in the WHO European Region (France, Germany, Italy and the United Kingdom). <b>All European <br />and North African cases have had a direct or indirect connection to the Middle East</b>. <span style="color: red;">In France, Italy, the United Kingdom and Tunisia there has been limited local transmission among close contacts who had not been to the Middle East but had been in contact with a sick traveller recently returned from the Middle East. </span><br /><b>The newest cases reported indicate that the source of infection remains active in the Middle East and is present throughout a large area.</b> The first case in Tunisia was likely infected in Qatar; however, this cannot be definitively shown without further investigation. Both the Tunisian and Qatari public health <br />authorities are pursuing further investigations. </div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /><b>The appearance of cases in Europe and North Africa but not in other countries with frequent travel in and out of the Middle East is likely a result of differences in surveillance and testing.</b> All Member States are encouraged to remind travellers returning from the affected area to seek medical attention if they develop a respiratory illness, and to test those who meet the profile described in the current surveillance recommendations posted on the WHO coronavirus web site.</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br />Human-to-human transmission has not been observed to persist beyond small clusters of individuals <br />with close contact. However, it is likely that more sporadic cases with subsequent limited transmission <br />will occur in the near future. The large number of cases with reported co-morbidities suggests that <br />persons with underlying medical conditions may have increased susceptibility to infection1<br />. <br />Convening of an Emergency Committee under the International Health Regulations (IHR)<br />WHO is convening an Emergency Committee under the IHR for MERS-CoV, which will meet on 9 and 11 <br />July 2013. The outcome of the Emergency Committee will be announced on the WHO web site and will <br />also be summarized in the next WHO/Europe MERS-CoV summary.<br />&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">&nbsp;</div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><b>Clinical presentation of MERS-CoV</b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /><b>The majority of cases have respiratory disease, from mild symptoms to severe pneumonia. The clinical <br />presentation includes acute respiratory illness with fever, cough, shortness of breath, breathing <br />difficulties and pneumonia. Atypical symptoms including diarrhoea and renal failure can be predominant <br />if the patient is immunocompromised. Recently, a small number of asymptomatic cases have been <br />detected through contact tracing among close contacts of cases. </b></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><br /></div><div id="content_div_193427" style="-webkit-text-stroke-width: 0px; background-color: white; color: black; font-family: arial, helvetica, verdana, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;"><a href="http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf">http://www.euro.who.int/__data/assets/pdf_file/0010/193492/MERS-CoV-EURO-update-9-July-FINAL.pdf</a></div><br>2013 2013 2013 <br> <a href="http://www.matrixar.com/" title="Matrix ">المصفوفة : أجمل الخلفيات والصور</a>

Guest
Guest


Back to top Go down

Back to top


 
Permissions in this forum:
You cannot reply to topics in this forum